RME Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Resmed Inc

Watchlist Manager

Watchlist

Price: 175.05 EUR -0.82%

Market Cap: €25.7B

R	Resmed Inc XMUN:RME	US
	Biodesix Inc NASDAQ:BDSX	US
F	Fortress Real Estate Investments Ltd JSE:FFB	ZA
M	Marathon Oil Corp BMV:MRO	US
	Apellis Pharmaceuticals Inc F:1JK	US
B	BlackBerry Ltd SWB:RI1	CA
H	HALEON PLC XBER:H6D	UK
A	Astron Corp Ltd ASX:ATR	AU
	Steven Madden Ltd F:SJM	US
	Japan Aviation Electronics Industry Ltd F:8N9	JP
	Mitsui & Co Ltd TSE:8031	JP
C	Canfor Corp OTC:CFPZF	CA

Profitability Summary

Resmed Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

62%

Strong 3Y Average Gross Margin

58%

Gross Margin is Increasing

56% > 62%

Exceptional Operating Margin

35%

Strong 3Y Average Operating Margin

31%

Operating Margin is Increasing

27% > 35%

Healthy Net Margin

27%

Sustainable 3Y Average Net Margin

24%

Net Margin is Increasing

21% > 27%

Exceptional Free Cash Flow Margin

31%

Strong 3Y Average Free Cash Flow Margin

27%

Free Cash Flow Margin is Increasing

13% > 31%

Exceptional ROE

25%

Positive 3Y Average ROE

Positive 3Y Average ROIC

19%

ROIC is Increasing

17% > 23%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.